Revive Therapeutics (TSXV:RVV; OTCQB:RVVTF) announced a new collaboration agreement with Chemi Pharmaceutical, a Licensed Dealer for cannabis pursuant to the Controlled Drugs and Substances Act under Health Canada and a laboratory approved by the US Food and Drug Administration (FDA).
As quoted in the press release:

The Agreement with Chemi Pharma strengthens Revive’s ambition in becoming a leader in the medical cannabis market. Under Chemi Pharma’s Dealer’s License, it enables Revive to conduct research, development, and analytical testing on the Company’s proprietary medical cannabis products, including its cannabinoid delivery system, and it unlocks the potential of Revive’s commercialization plans and partnering with Canadian licensed producers of medical cannabis pursuant to the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). Revive is commercializing novel medical cannabis products targeting liver disease, pain, dermatology and rare diseases with US FDA approval for orphan drug designation while leveraging technologies such as blockchain and artificial intelligence (“AI”) or machine learning to support the Company’s objectives.
“We are very excited with our collaboration with Chemi Pharma as it serves as an important part of our strategy in becoming a global leader in the medical cannabis industry while unlocking opportunities in partnering with pharmaceutical companies and licensed producers of medical cannabis,” said Fabio Chianelli, President of Revive.


Click here to read the full press release.

Source: www.marketwired.com

– FinCanna Capital Corp. (CSE:CALI) (OTCQB:FNNZF), based in Vancouver, BC today announced that Andriyko Herchak, CEO, will present live at VirtualInvestorConferences.com on December 3 rd .

Keep reading... Show less

First-of-its-kind trial in Canada will pave the way for expanded MDMA-assisted treatment to support patients with posttraumatic stress disorder

Keep reading... Show less

Multi-year partnership designates BioSteel as new official sports drink of Philadelphia 76ers team, Training Complex, and the presenting partner of 76ers Training Camp

BioSteel today announced a multi-year deal with the Philadelphia 76ers, making the sports hydration company the official sports drink of the team. BioSteel will also serve as a partner of the Philadelphia 76ers Training Complex, and the presenting partner for 76ers Training Camp, which begins next week.

Keep reading... Show less

Achievements with Scalability and Compatibility Pave Way for Next Phase of Advancement

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) is excited to announce that the Company’s holding, Arcology, a cluster-computing powered AI blockchain ecosystem with unlimited scalability, has updated its working roadmap in response to its Testnet 1.0 results

Keep reading... Show less

For the purposes of the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules, World High Life announces that the Company has 230,119,819 ordinary shares of 1p each in issue (“Ordinary Shares”), each share carrying the right to one vote. The figure of 230,119,819 should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules

The Directors of the Company accept responsibility for the contents of this announcement.

Keep reading... Show less